Acute Leukemias

9 registered clinical trials studyying Acute Leukemias — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participan NCT05521087	Janssen Research & Development, LLC	Phase 1
Recruiting	A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia NCT07295951	Janssen Research & Development, LLC	Phase 1
Recruiting	A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) NCT04811560	Janssen Research & Development, LLC	Phase 1 / Phase 2
Terminated	Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases NCT02145039	Masonic Cancer Center, University of Minnesota	N/A
Completed	A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Re NCT02141828	Epizyme, Inc.	Phase 1
Completed	Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia NCT01826214	Novartis Pharmaceuticals	Phase 2
Withdrawn	Providing Access to Cord Blood Units for Transplants NCT01479582	National Cancer Institute (NCI)	Phase 2
Unknown	Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological M NCT01339988	Tel-Aviv Sourasky Medical Center	Phase 4
Unknown	Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells NCT01919866	University Children's Hospital Tuebingen	Phase 1 / Phase 2